Real-world data show the effect of statins in primary prevention

Eur J Prev Cardiol. 2023 Nov 30;30(17):1881-1882. doi: 10.1093/eurjpc/zwad231.

Authors

Julian E Mariampillai¹, Sverre E Kjeldsen^{2

3}

Affiliations

¹ Department of Internal Medicine, Lovisenberg Diaconal Hospital, PB 4970 Nydalen, Oslo, Norway.
² Departments of Cardiology and Nephrology, Oslo University Hospital, Oslo, Norway.
³ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

PMID: 37439146
DOI: 10.1093/eurjpc/zwad231

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Diabetes Mellitus*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Hypertension*
Primary Health Care
Primary Prevention

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors